Business Description
Humanigen Inc
NAICS : 325412
SIC : 2834
ISIN : US4448631048
Description
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.14 | |||||
| 9-Day RSI | 45.99 | |||||
| 14-Day RSI | 45.83 | |||||
| 6-1 Month Momentum % | 200 | |||||
| 12-1 Month Momentum % | -99.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3785.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -0.04 | |||||
| EV-to-Forward-EBITDA | -0.04 | |||||
| EV-to-Forward-Revenue | 0.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HGENQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humanigen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.699 | ||
| EPS (TTM) ($) | -0.54 | ||
| Beta | 0 | ||
| Volatility % | 184.85 | ||
| 14-Day RSI | 45.83 | ||
| 14-Day ATR ($) | 0.000155 | ||
| 20-Day SMA ($) | 0.0002 | ||
| 12-1 Month Momentum % | -99.84 | ||
| 52-Week Range ($) | 0.00001 - 0.207 | ||
| Shares Outstanding (Mil) | 119.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humanigen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humanigen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humanigen Inc Frequently Asked Questions
What is Humanigen Inc(HGENQ)'s stock price today?
The current price of HGENQ is $0.00. The 52 week high of HGENQ is $0.21 and 52 week low is $0.00.
When is next earnings date of Humanigen Inc(HGENQ)?
The next earnings date of Humanigen Inc(HGENQ) is 2024-11-29 Est..
Does Humanigen Inc(HGENQ) pay dividends? If so, how much?
Humanigen Inc(HGENQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers